New figures released by the NHS show that opt-out testing pilots have identified more than 3,500 previously undiagnosed cases of HIV, Hepatitis B and Hepatitis C since April 2022.
The trials, which cost £20m, were designed to identify cases in people unlikely to get tested at a sexual health clinic.
The UK Health Security Agency, which has been leading the pilots, says opt-out testing is more likely to lead to an early diagnosis, which they say will save the NHS money in the long term.
